CurrentEndo
Get Weekly

Topic · page 3 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 81–120 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. Osteoporos Int

    Romosozumab in severe postmenopausal osteoporosis—real-world data from 192 women

    Cohort study

  2. J Bone Miner Res

    Abnormal position of a GNAS methylation regulatory element causes autosomal dominant pseudohypoparathyroidism type 1B (PHP1B)

    Research article

  3. Osteoporos Int

    Denosumab therapy is associated with a reduced risk of clinically diagnosed rotator cuff tears: a multi-institutional real-world cohort study

    Cohort study

  4. Endocr Pract

    Insights from Secular Trend of Major Osteoporotic Fractures in People with and without Diabetes: 15-Year Population-based Study (2009–2023)

    Cohort study

  5. Pituitary

    Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women?

    Cross-sectional study

  6. Osteoporos Int

    Association between myosteatosis and bone mineral density in postmenopausal women

    Cross-sectional study

  7. JAMA Netw Open

    Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors

    Cohort study

  8. Eur J Endocrinol

    Improving postthyroidectomy care using a parathyroid hormone and calcium-based algorithm

    Cohort study

  9. Osteoporos Int

    Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates

    Randomized controlled trial

  10. Osteoporos Int

    Revisiting the Osteoporosis Self-Assessment Tool (OST): evidence from a multi-cohort study in Asia supporting age-dependent thresholds

    Diagnostic or prognostic study

  11. Osteoporos Int

    Multimorbidity patterns among fragility fracture patients aged 50 + years in China and the US

    Cross-sectional study

  12. Diabetes Metab

    Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors

    Cohort study

  13. J Bone Miner Res

    Alendronate for 6 or 12 mo following denosumab discontinuation in women with postmenopausal osteoporosis: a prospective observational study

    Cohort study

  14. J Bone Miner Res

    Increased prevalence of coronary artery calcification in patients with post-surgical hypoparathyroidism

    Cross-sectional study

  15. Eur J Endocrinol

    Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia

    Cohort study

  16. Osteoporos Int

    Weight changes after smoking cessation and the risk of hip fractures: a nationwide population-based cohort study

    Cohort study

  17. J Bone Miner Res

    Race-neutral FRAX outperforms FRAX without BMD in a multiethnic cohort with diabetes or hypertension

    Cohort study

  18. Osteoporos Int

    Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation

    Guideline or statement

  19. J Bone Miner Res

    Women’s musculoskeletal health: insights from the 2024 National Academies of Sciences, Engineering, and Medicine report on chronic conditions

    Guideline or statement

  20. Osteoporos Int

    AI-derived bone mineral density from standard radiographs compared with DXA for fracture prediction in a 10-year real-world cohort study

    Cohort study

  21. Osteoporos Int

    Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study

    Cohort study

  22. Osteoporos Int

    Risk of medication-related osteonecrosis of the jaw during romosozumab treatment

    Cohort study

  23. J Bone Miner Res

    Central giant cell granuloma: a decade of institutional experience and curative potential of neoadjuvant denosumab

    Cohort study

  24. J Bone Miner Res

    Complement factor H (CFH), an immune factor enhances osteoblast differentiation and correlates with bone density

    Mechanistic study

  25. Osteoporos Int

    Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial

    Randomized controlled trial

  26. Clin Endocrinol (Oxf)

    Preoperative CALLY Index for Identifying Atypical Parathyroid Tumors

    Case-control study

  27. Eur Thyroid J

    Hypercalcitoninemia in chronic kidney disease: an old issue, a new perspective?

    Cross-sectional study

  28. Osteoporos Int

    Association between vestibular dysfunction and osteoporosis in adults: a systematic review and meta-analysis

    Meta-analysis

  29. Endocr Pract

    Denosumab and Risk of Type 2 Diabetes Risk Among Patients With Osteoporosis: A Retrospective Cohort Study

    Cohort study

  30. Endocr Pract

    Efficacy and Safety of Denosumab versus Zoledronic Acid in the Treatment of Hypercalcemia in Primary Hyperparathyroidism: A Retrospective Comparative Study

    Cohort study

  31. Osteoporos Int

    Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk

    Cohort study

  32. Obesity (Silver Spring)

    Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults

    Cohort study

  33. Diabetes Care

    Diabetes and Femoral Fracture Patterns: A Nationwide Registry Study (1997–2021)

    Cohort study

  34. Osteoporos Int

    “Don’t tell me I’m going to feel joy”: The emotional burden of informal caregivers of patients with a fragility fracture discharged from a rehabilitation hospital

    Research article

  35. J Bone Miner Res

    Automated abdominal aortic calcification, muscle health, and incident falls: the UK Biobank Imaging Study

    Cohort study

  36. J Bone Miner Res

    Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial

    Secondary analysis

  37. Osteoporos Int

    Diabetes progression and its association with fracture risk in type 2 diabetes

    Cohort study

  38. Osteoporos Int

    Efficacy of denosumab versus zoledronate on preventing secondary osteoporotic vertebral compression fracture: a prospective study with 2-year follow-up

    Randomized controlled trial

  39. BMJ

    Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis

    Meta-analysis

  40. Eur J Endocrinol

    Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment

    Cohort study

All 1,367 Briefs in ExploreShowing Briefs 81–120 of 1,367, newest first